Subscribe
Conference Correspondent

Why CDK4/6 Inhibitors Are Effective in HR-Positive Metastatic Breast Cancer

Breast Cancer, Video, SABCS
Conference Correspondent 
Dr Hope Rugo cites that CDK4/6 inhibitors play a critical role in estrogen signaling and can be very effective in treating metastatic breast cancer when used in combination with hormone therapy.

Related Items

Adjuvant T-DM1 Improves Survival vs Trastuzumab in Early High-Risk HER2-Positive Breast Cancer
By Phoebe Starr
TON - February 2024 Vol 17, No 1
Breast Cancer, SABCS
HER2-Directed Combination Improves Outcomes in Advanced HER2-Positive Breast Cancer, Including Patients With Brain Metastases
By Wayne Kuznar
TON - February 2024 Vol 17, No 1
SABCS
Supervised Exercise Program Enhances Quality of Life and Fitness in Patients With Metastatic Breast Cancer
By Wayne Kuznar
TON - February 2024 Vol 17, No 1
SABCS, Breast Cancer
Ribociclib Plus Endocrine Therapy Improves Invasive Disease-Free Survival in Patients With HR-Positive, HER2-Negative, Early Breast Cancer
By Patricia Stewart
Web Exclusives
ASCO 2023 Highlights, Breast Cancer
Pausing Endocrine Therapy to Become Pregnant Appears Safe for Women with Breast Cancer
By Patricia Stewart
TON - April 2023 Vol 16, No 2
Breast Cancer, SABCS 2023
Ribociclib plus Endocrine Treatment Outperforms Chemotherapy in Advanced Breast Cancer
By William King
TON - February 2023 Vol 16, No 1
Breast Cancer, SABCS
CTC Count May Help Providers Choose Optimal Therapy for Patients with Metastatic Breast Cancer
By William King
TON - February 2023 Vol 16, No 1
SABCS, Breast Cancer
Addition of Capivasertib to Fulvestrant Improves Outcomes in Metastatic Breast Cancer
By William King
TON - February 2023 Vol 16, No 1
SABCS, Breast Cancer
Radiation Therapy May Be Safely Omitted for Some Older Patients with Luminal A Breast Cancer
By Patricia Stewart
TON - October 2022 Vol 15, No 5
Breast Cancer
Key Factors Associated with Early Discontinuation of Abemaciclib in Patients with Breast Cancer in the MonarchE Trial
By William King
TON - October 2022 Vol 15, No 5
Breast Cancer

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Sign Up for The Oncology Nurse®‑APN/PA

Subscribe to receive the free, monthly TON print publication and TON weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.